Frankfurt - Delayed Quote EUR
Novavax, Inc. (NVV1.F)
6.28
+0.04
+(0.66%)
As of 8:08:11 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-189,210
-87,263
-713,967
-415,937
322,946
Investing Cash Flow
-270,107
-204,038
-58,806
-92,985
100,154
Financing Cash Flow
247,636
260,583
4,466
324,988
461,713
End Cash Position
284,255
545,292
583,810
1,348,845
1,528,259
Income Tax Paid Supplemental Data
--
949
190
17,980
12,606
Interest Paid Supplemental Data
19,165
17,572
17,349
18,035
19,428
Capital Expenditure
-8,984
-14,639
-58,806
-92,985
-57,486
Issuance of Capital Stock
256,410
263,272
360,243
249,230
564,859
Issuance of Debt
--
0
0
175,250
0
Repayment of Debt
-5,835
-3,994
-352,345
-93,595
-127,907
Free Cash Flow
-198,194
-101,902
-772,773
-508,922
265,460
12/31/2021 - 2/1/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
25I.SG ImmuPharma PLC
0.0265
+17.78%
600161.SS TIANTAN BIO
19.23
+1.26%
PRTCl.XC
ATOS.MX Atossa Therapeutics, Inc.
16.00
-15.79%
4880.T CellSource Co., Ltd.
686.00
-1.01%
AYJ.DE Valneva SE
2.8280
+0.14%
RXK3.MU SELLAS Life Sciences Group Inc
1.5920
-5.13%
NANOFS.ST Nanoform Finland Oyj
10.12
-4.17%
4BB.L 4basebio PLC
1,150.00
+3.60%
22Z.SG Zealand Pharma A/S
60.72
+0.93%